Singapore, June 27 -- German firm Covestro has launched production of its new Desmopan(R) Rx medical-grade Thermoplastic Polyurethane (TPU) at its Changhua site in Taiwan, which has recently been qualified for medical-grade TPU manufacturing.

As Covestro's second facility worldwide-after New Martinsville in North America-qualified to produce medical-grade TPU, the Changhua site localised production of these high-standard materials in Asia Pacific, enabling more flexible and efficient regional supply to meet growing demand.

Produced at the Changhua site in accordance with Good Manufacturing Practice (GMP) principles, the new Desmopan(R) Rx grades are engineered to meet stringent international requirements for medical applications and min...